Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,161 to 1,180 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Common variable immunodeficiency in two kindreds with heterogeneous phenotypes caused by novel heterozygous NFKB1 mutations. | Front Immunol | 2022 | 36203612 | PubTator, text mining | PubMed |
| Pan-Cancer Gene Analysis of m6A Modification and Immune Infiltration in Uterine Corpus Endometrial Carcinoma. | Comput Intell Neurosci | 2022 | 36199963 | PubTator, text mining | PubMed |
| Screening of Sepsis Biomarkers Based on Bioinformatics Data Analysis. | J Healthc Eng | 2022 | 36199375 | PubTator, text mining | PubMed |
| Subclones of bone marrow CD34+ cells in acute myeloid leukemia at diagnosis confer responses of patients to induction chemotherapy. | Cancer | 2022 | 36197314 | PubTator, text mining | PubMed |
| B cells defined by immunoglobulin isotypes. | Clin Exp Immunol | 2022 | 36197112 | PubTator, text mining | PubMed |
| Cancer-associated fibroblast-derived gene signatures predict radiotherapeutic survival in prostate cancer patients. | J Transl Med | 2022 | 36195908 | PubTator, text mining | PubMed |
| Lupus nephritis: The regulatory interplay between epigenetic and MicroRNAs. | Front Physiol | 2022 | 36187762 | PubTator, text mining | PubMed |
| Trogocytosis in innate immunity to cancer is an intimate relationship with unexpected outcomes. | iScience | 2022 | 36185368 | PubTator, text mining | PubMed |
| Identification and validation of a novel necroptosis-related prognostic signature in cervical squamous cell carcinoma and endocervical adenocarcinoma. | Front Oncol | 2022 | 36185274 | PubTator, text mining | PubMed |
Conversion therapy from unresectable stage IIIC non-small-cell lung cancer to radical surgery via anti-PD-1 immunotherapy combined with chemotherapy and anti-angiogenesis: A case report and literature review. | Front Oncol | 2022 | 36185263 | PubTator, text mining | PubMed |
| Single cell sequencing analysis and transcriptome analysis constructed the liquid-liquid phase separation(LLPS)-related prognostic model for endometrial cancer. | Front Oncol | 2022 | 36185238 | PubTator, text mining | PubMed |
| FAIM2 is a potential pan-cancer biomarker for prognosis and immune infiltration. | Front Oncol | 2022 | 36185230 | PubTator, text mining | PubMed |
| A transcriptional metastatic signature predicts survival in clear cell renal cell carcinoma. | Nat Commun | 2022 | 36180422 | PubTator, text mining | PubMed |
| Targeting epigenetic regulators for inflammation: Mechanisms and intervention therapy. | MedComm (2020) | 2022 | 36176733 | PubTator, text mining | PubMed |
| KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape. | Nat Med | 2022 | 36175679 | PubTator, text mining | PubMed |
| Clinical advances and ongoing trials on mRNA vaccines for cancer treatment. | Lancet Oncol | 2022 | 36174631 | PubTator, text mining | PubMed |
| Autologous blood extracellular vesicles and specific CD4+ T-cell co-activation. | Front Immunol | 2022 | 36172364 | PubTator, text mining | PubMed |
| Integrated single-cell RNA-seq analysis identifies immune heterogeneity associated with KRAS/TP53 mutation status and tumor-sideness in colorectal cancers. | Front Immunol | 2022 | 36172359 | PubTator, text mining | PubMed |
| Pan-cancer analysis of a novel indicator of necroptosis with its application in human cancer. | Aging (Albany NY) | 2022 | 36170029 | PubTator, text mining | PubMed |
| Potential of mRNA vaccines to become versatile cancer vaccines. | World J Clin Oncol | 2022 | 36160466 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=59